loading
Rocket Pharmaceuticals Inc stock is traded at $3.785, with a volume of 493.17K. It is up +0.11% in the last 24 hours and up +16.07% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.78
Open:
$3.78
24h Volume:
493.17K
Relative Volume:
0.14
Market Cap:
$408.96M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.3764
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
+1.18%
1M Performance:
+16.07%
6M Performance:
-50.41%
1Y Performance:
-77.70%
1-Day Range:
Value
$3.72
$3.84
1-Week Range:
Value
$3.72
$4.07
52-Week Range:
Value
$2.19
$18.17

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Name
Rocket Pharmaceuticals Inc
Name
Phone
646-440-9100
Name
Address
350 FIFTH AVENUE, NEW YORK, NY
Name
Employee
299
Name
Twitter
@rocketpharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
RCKT's Discussions on Twitter

Compare RCKT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
3.79 407.88M 0 -258.08M -202.32M -2.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.80 106.97B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
658.48 68.62B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
444.18 63.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
815.88 50.61B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
191.23 35.29B 398.11M -1.03B -868.57M -5.7032

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-20-25 Upgrade BofA Securities Neutral → Buy
Jul-25-25 Downgrade BofA Securities Buy → Neutral
May-30-25 Downgrade Evercore ISI Outperform → In-line
May-28-25 Downgrade Goldman Neutral → Sell
May-28-25 Downgrade JP Morgan Overweight → Neutral
May-28-25 Downgrade Jefferies Buy → Hold
May-28-25 Downgrade Leerink Partners Outperform → Market Perform
May-28-25 Downgrade Morgan Stanley Overweight → Equal-Weight
May-27-25 Downgrade Needham Buy → Hold
May-27-25 Downgrade TD Cowen Buy → Hold
Mar-12-25 Initiated BMO Capital Markets Outperform
Dec-30-24 Initiated Wedbush Outperform
Dec-18-24 Initiated Jefferies Buy
Oct-16-24 Initiated Scotiabank Sector Outperform
Apr-02-24 Initiated Goldman Neutral
Oct-24-23 Initiated Cantor Fitzgerald Overweight
Feb-01-23 Initiated Morgan Stanley Overweight
Nov-08-22 Initiated Canaccord Genuity Buy
Nov-01-22 Initiated BTIG Research Buy
Jul-08-22 Initiated Raymond James Outperform
Oct-20-21 Resumed Cowen Outperform
Mar-02-21 Initiated Stifel Buy
Feb-18-21 Initiated Needham Buy
Dec-16-20 Initiated UBS Buy
Dec-08-20 Downgrade Oppenheimer Outperform → Perform
Jul-02-20 Initiated JP Morgan Overweight
Jun-25-20 Resumed BofA/Merrill Buy
Jun-01-20 Resumed Oppenheimer Outperform
Nov-06-19 Initiated Chardan Capital Markets Buy
Sep-26-19 Initiated Piper Jaffray Overweight
Apr-23-19 Initiated Robert W. Baird Outperform
Mar-15-19 Initiated BofA/Merrill Buy
Feb-05-19 Initiated Oppenheimer Outperform
Sep-13-18 Initiated Ladenburg Thalmann Buy
Jul-10-18 Initiated William Blair Outperform
View All

Rocket Pharmaceuticals Inc Stock (RCKT) Latest News

pulisher
07:39 AM

Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growthBear Alert & Low Drawdown Momentum Trade Ideas - newser.com

07:39 AM
pulisher
07:34 AM

Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued historicallyEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com

07:34 AM
pulisher
07:34 AM

Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com

07:34 AM
pulisher
07:29 AM

Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationTrade Ideas & Weekly Top Gainers Trade List - newser.com

07:29 AM
pulisher
06:17 AM

Published on: 2025-10-30 05:17:46 - newser.com

06:17 AM
pulisher
05:49 AM

Is Rocket Pharmaceuticals Inc. Equity Warrant stock a safe haven assetEarnings Performance Report & Weekly Sector Rotation Insights - newser.com

05:49 AM
pulisher
04:50 AM

Sentiment analysis tools applied to Rocket Pharmaceuticals Inc.New Guidance & Verified Swing Trading Watchlist - newser.com

04:50 AM
pulisher
03:59 AM

Is Rocket Pharmaceuticals Inc. stock entering bullish territoryQuarterly Profit Summary & Smart Allocation Stock Reports - newser.com

03:59 AM
pulisher
03:38 AM

Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell offWeekly Trade Review & Capital Efficient Trading Techniques - newser.com

03:38 AM
pulisher
02:49 AM

Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts wealthy investors2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com

02:49 AM
pulisher
02:46 AM

Analyzing Rocket Pharmaceuticals Inc. Equity Warrant with risk reward ratio chartsTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com

02:46 AM
pulisher
02:14 AM

Rocket Pharmaceuticals Inc. stock chart pattern explainedEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com

02:14 AM
pulisher
Oct 29, 2025

Why Rocket Pharmaceuticals Inc. stock is in analyst buy zone2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Trading Recap & Reliable Breakout Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock recover after recent dropWeekly Trend Summary & Entry Point Confirmation Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What machine learning models say about Rocket Pharmaceuticals Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What’s next for Rocket Pharmaceuticals Inc. stock price2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What dividend safety score for Rocket Pharmaceuticals Inc. stockInsider Selling & Verified Swing Trading Watchlist - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarksTrade Exit Summary & Consistent Return Investment Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumMarket Volume Summary & Weekly High Conviction Ideas - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 03:40:12 - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Price momentum metrics for Rocket Pharmaceuticals Inc. explained2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Rocket Pharmaceuticals Inc. stock attractive for passive investorsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresDividend Hike & Risk Controlled Daily Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How to integrate Rocket Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 21:44:10 - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Rocket Pharmaceuticals Inc. stock compares to industry benchmarksAnalyst Upgrade & Daily Oversold Bounce Ideas - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. (RCKT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to oil prices2025 Major Catalysts & Long-Term Growth Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Will a bounce in Rocket Pharmaceuticals Inc. offer an exit2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Applying big data sentiment scoring on Rocket Pharmaceuticals Inc.Weekly Trading Summary & Expert Verified Movement Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What technical models suggest about Rocket Pharmaceuticals Inc.’s comebackTake Profit & Precise Swing Trade Entry Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts HNW investors2025 Retail Activity & Fast Gain Swing Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Heatmap analysis for Rocket Pharmaceuticals Inc. Equity Warrant and competitorsNew Guidance & Intraday High Probability Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Rocket Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Custom strategy builders for tracking Rocket Pharmaceuticals Inc.July 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 02:19:15 - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain double digit ROEWeekly Profit Summary & Technical Buy Zone Confirmations - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

How institutional ownership impacts Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Rocket Pharmaceuticals Inc. Equity Warrant stock beat market expectations this quarterJuly 2025 Volume & Technical Entry and Exit Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Why Rocket Pharmaceuticals Inc. stock remains on buy listsRate Hike & Safe Capital Growth Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Rocket Pharmaceuticals Inc. recovery potential after sell offJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com

Oct 28, 2025

Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.13
price up icon 1.27%
$93.61
price up icon 4.01%
$28.80
price down icon 0.55%
$105.37
price up icon 1.95%
biotechnology ONC
$309.24
price down icon 1.79%
$191.00
price up icon 14.02%
Cap:     |  Volume (24h):